GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $129,493,000 | +4147.1% | 1,901,518 | +1725.7% | 0.40% | +3880.0% |
Q4 2021 | $3,049,000 | -88.2% | 104,154 | -78.7% | 0.01% | -94.2% |
Q1 2019 | $25,827,000 | +67.5% | 487,948 | +29.9% | 0.17% | +55.0% |
Q4 2018 | $15,418,000 | +755.1% | 375,593 | +742.1% | 0.11% | +1287.5% |
Q3 2018 | $1,803,000 | -56.4% | 44,602 | -51.3% | 0.01% | -57.9% |
Q2 2018 | $4,140,000 | -60.6% | 91,574 | -57.9% | 0.02% | -56.8% |
Q1 2018 | $10,516,000 | +3809.3% | 217,720 | +2409.2% | 0.04% | +4300.0% |
Q3 2017 | $269,000 | -44.1% | 8,677 | -71.4% | 0.00% | -66.7% |
Q1 2016 | $481,000 | – | 30,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |